[1]CurrentPatentAssignee:TAKEDAPHARMACEUTICALCOMPANYLIMITED-US4725610,1988,A
[2]Sohda;Mizuno;Momose;Ikeda;Fujita;Meguro[JournalofMedicinalChemistry,1992,vol.35,#14,p.2617-2626]
[1]JournalofMedicinalChemistry,1992,vol.35,p.2617-2626
[1]Sohda;Mizuno;Momose;Ikeda;Fujita;Meguro[JournalofMedicinalChemistry,1992,vol.35,#14,p.2617-2626]
[1]JournalofMedicinalChemistry,2000,vol.43,p.3052-3066
[1]CurrentPatentAssignee:THERACOSINC-US2003/181494,2003,A1
[2]Fan,Yun-Hua;Chen,Han;Natarajan,Amarnath;Guo,Yuhong;Harbinski,Fred;Iyasere,Julia;Christ,William;Aktas,Huseyin;Halperin,JoseA.[BioorganicandMedicinalChemistryLetters,2004,vol.14,#10,p.2547-2550]
[3]CurrentPatentAssignee:HYUNDAIPHARM.CO.,LTD-WO2013/105753,2013,A1Locationinpatent:Paragraph137;138;139;140;141
Title: Chemical proteomics-based analysis of off-target binding profiles for rosiglitazone and pioglitazone: clues for assessing potential for cardiotoxicity.
Journal: Journal of medicinal chemistry 20121011
Title: A novel binding assay identifies high affinity ligands to the rosiglitazone binding site of mitoNEET.
Journal: Bioorganic & medicinal chemistry letters 20110915
Title: Structure-activity relationship and docking studies of thiazolidinedione-type compounds with monoamine oxidase B.
Journal: Bioorganic & medicinal chemistry letters 20110815
Title: Structure-activity requirements for the antiproliferative effect of troglitazone derivatives mediated by depletion of intracellular calcium.
Journal: Bioorganic & medicinal chemistry letters 20040517